Clearance Summary
SCIMED OPTAMUM OPER PERIPHERAL ANGIOPLASTY CATH received FDA 510(k) clearance under submission number K910155, sponsored by Scimed Life Systems, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 1991-02-07.
- Submission: K910155
- Applicant / Sponsor: Scimed Life Systems, Inc.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1250
- Decision date: 1991-02-07
Classification & Regulation
This clearance is catalogued under FDA product code LIT and 21 CFR 870.1250, within the Cardiovascular review panel as a Class II device.